Christopher M. Hall — President and Chief Operating Officer at Veracyte

Mr. Christopher M. Hall, also known as Chris, has been the President and Chief Operating Officer at Veracyte, Inc. since February 28, 2017 and September 17, 2014 respectively. Mr. Hall served as the Chief Commercial Officer of Veracyte, Inc. since March 2010 until September 2014. Mr. Hall served as Chief Business Officer of Berkeley HeartLab, Inc., a subsidiary of Celera Corporation since October 2008. He served as Senior Vice President of Celera Corporation. He served as Vice President of Celera Corporation. He served several executive and senior positions at Berkeley HeartLab, or BHL for seven years, including Chief Clinical Operations Officer from 2005 to 2008 and also as Chief of Marketing. He served as Vice President of Clinical Operations of Berkeley HeartLab, Inc. He joined Berkeley in 2001. He served as Vice President of Marketing at BHL, where he was instrumental in repositioning BHL from a specialty laboratory for advanced lipid blood tests to a cardiovascular disease management company. He served as Vice President, Product Management at Asimba, Inc. He worked in Business Development at Kenan Systems selling billing and customer applications to telecommunications carriers and did strategy consulting work at Symmetrix (Nextera). Mr. Hall holds Bachelor of Arts from DePauw University, Greencastle, in 1990 and MBA from the Harvard University, Boston, MA in 1994.